Arcadia Biosciences (RKDA) Reports Q2 Loss Per Share of $0.19
Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.19), versus ($3.08) reported last year. Revenue for the quarter came in at $1.43 million, versus $1.31 million reported last year.
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.
